IPHA NASDAQ
Innate Pharma S.A.
1W: -8.2%
1M: -28.1%
3M: -16.6%
YTD: -14.3%
1Y: -21.2%
3Y: -39.5%
5Y: -76.7%
$1.56
-0.03 (-1.89%)
Weekly Expected Move ±6.7%
$1
$1
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$51M
-634.8% ▼
Capital Expenditures
$134K
+65.6% ▲
5Y CAGR: -58.8%
Free Cash Flow
-$51M
-597.2% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$30M
-623.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$53M | -$58M | -$8M | -$49M | -$47M |
| Depreciation & Amort. | $5M | $45M | $5M | $2M | $1M |
| Stock-Based Comp. | $3M | $4M | $4M | $4M | $0 |
| Change in Working Capital | -$10M | -$13M | -$32M | $39M | -$10M |
| Other Non-Cash Items | -$1M | $2M | -$2M | -$3M | $5M |
| Operating Cash Flow | -$58M | -$19M | -$33M | -$7M | -$51M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$1M | -$351K | -$391K | -$134K |
| Acquisitions (Net) | $7K | $0 | $0 | $0 | $5K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $3M | $23M | $10M | $14M |
| Other Investing | $406K | -$1K | -$2M | $1K | -$6M |
| Investing Cash Flow | -$917K | $2M | $21M | $9M | $7M |
| — Financing Activities — | |||||
| Net Debt Issuance | $27M | -$2M | -$2M | -$9M | -$9M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $187K | $0 | $395K | $3M | $0 |
| Financing Cash Flow | $27M | -$2M | -$2M | -$6M | $6M |
| Net Change in Cash | -$33M | -$20M | -$14M | -$4M | -$30M |
| Cash End of Period | $104M | $84M | $71M | $66M | $28M |
| Free Cash Flow | -$60M | -$20M | -$35M | -$7M | -$51M |